Action Point Financial Planning’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-149
Closed -$8.24K – 678
2026
Q2
$8.24K Buy
+149
New +$8.16K ﹤0.01% 1554

Other funds holding BMRN

Action Point Financial Planning's BMRN Position: Q3 2026 in Review

Action Point Financial Planning sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2026, closing a stake of 149 shares — an estimated $8.24K sold.

Action Point Financial Planning first reported a position in BMRN in Q2 2026 and held it in 1 quarter. The position peaked at $8.24K in Q2 2026. 567 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • Action Point Financial Planning reported no remaining BioMarin Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 149 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $8.24K.
  • Action Point Financial Planning first reported a position in BioMarin Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's BioMarin Pharmaceuticals position peaked at $8.24K in Q2 2026.
  • 567 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.